APA

Salonen K. M., Ryhänen S. J., Forbes J. M., Härkönen T., Ilonen J., Simell O., Veijola R., Groop P. & Knip M. (20180305). A drop in the circulating concentrations of soluble receptor for advanced glycation end products is associated with seroconversion to autoantibody positivity but not with subsequent progression to clinical disease in children en route to type 1 diabetes. : Diabetes/metabolism research and reviews.

Chicago

Salonen K M, Ryhänen S J, Forbes J M, Härkönen T, Ilonen J, Simell O, Veijola R, Groop P-H and Knip M. 20180305. A drop in the circulating concentrations of soluble receptor for advanced glycation end products is associated with seroconversion to autoantibody positivity but not with subsequent progression to clinical disease in children en route to type 1 diabetes. : Diabetes/metabolism research and reviews.

Harvard

Salonen K. M., Ryhänen S. J., Forbes J. M., Härkönen T., Ilonen J., Simell O., Veijola R., Groop P. and Knip M. (20180305). A drop in the circulating concentrations of soluble receptor for advanced glycation end products is associated with seroconversion to autoantibody positivity but not with subsequent progression to clinical disease in children en route to type 1 diabetes. : Diabetes/metabolism research and reviews.

MLA

Salonen K M, Ryhänen S J, Forbes J M, Härkönen T, Ilonen J, Simell O, Veijola R, Groop P-H and Knip M. A drop in the circulating concentrations of soluble receptor for advanced glycation end products is associated with seroconversion to autoantibody positivity but not with subsequent progression to clinical disease in children en route to type 1 diabetes. : Diabetes/metabolism research and reviews. 20180305.